AMRX
Price
$9.62
Change
+$0.07 (+0.73%)
Updated
Sep 5 closing price
Capitalization
3.02B
62 days until earnings call
HROW
Price
$36.99
Change
+$0.79 (+2.18%)
Updated
Sep 5 closing price
Capitalization
1.37B
72 days until earnings call
Interact to see
Advertisement

AMRX vs HROW

Header iconAMRX vs HROW Comparison
Open Charts AMRX vs HROWBanner chart's image
Amneal Pharmaceuticals
Price$9.62
Change+$0.07 (+0.73%)
Volume$1.27M
Capitalization3.02B
Harrow
Price$36.99
Change+$0.79 (+2.18%)
Volume$355.52K
Capitalization1.37B
AMRX vs HROW Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. HROW commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Buy and HROW is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AMRX: $9.62 vs. HROW: $36.99)
Brand notoriety: AMRX and HROW are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 86% vs. HROW: 66%
Market capitalization -- AMRX: $3.02B vs. HROW: $1.37B
AMRX [@Pharmaceuticals: Generic] is valued at $3.02B. HROW’s [@Pharmaceuticals: Generic] market capitalization is $1.37B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileHROW’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • HROW’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMRX and HROW are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • HROW’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRX and HROW are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а +0.63% price change this week, while HROW (@Pharmaceuticals: Generic) price change was -5.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

HROW is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($3.02B) has a higher market cap than HROW($1.37B). AMRX YTD gains are higher at: 21.465 vs. HROW (10.253). AMRX has higher annual earnings (EBITDA): 584M vs. HROW (32.1M). AMRX has more cash in the bank: 71.5M vs. HROW (53M). HROW has less debt than AMRX: HROW (231M) vs AMRX (2.58B). AMRX has higher revenues than HROW: AMRX (2.85B) vs HROW (228M).
AMRXHROWAMRX / HROW
Capitalization3.02B1.37B221%
EBITDA584M32.1M1,819%
Gain YTD21.46510.253209%
P/E Ratio962.00N/A-
Revenue2.85B228M1,251%
Total Cash71.5M53M135%
Total Debt2.58B231M1,118%
FUNDAMENTALS RATINGS
AMRX vs HROW: Fundamental Ratings
AMRX
HROW
OUTLOOK RATING
1..100
2615
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
5049
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
4343
P/E GROWTH RATING
1..100
3111
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HROW's Valuation (83) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's Profit vs Risk Rating (49) in the Pharmaceuticals Other industry is in the same range as AMRX (50) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as AMRX (43) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is in the same range as AMRX (31) in the Pharmaceuticals Major industry. This means that HROW’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXHROW
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIOIX13.830.04
+0.29%
M3Sixty Income and Opportunity Instl
PJNQX63.16N/A
N/A
PGIM Jennison Natural Resources R6
HDCVX17.49N/A
N/A
Janus Henderson International Div C
RDWGX12.79N/A
N/A
American Funds Dvlpg Wld Gr&Inc R6
PLGJX10.82N/A
N/A
Principal LargeCap Growth I J

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.73%
PAHC - AMRX
46%
Loosely correlated
+0.97%
VTRS - AMRX
44%
Loosely correlated
+1.65%
TEVA - AMRX
40%
Loosely correlated
+2.54%
COLL - AMRX
39%
Loosely correlated
-2.32%
ALKS - AMRX
38%
Loosely correlated
+3.53%
More

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with OGI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+2.18%
OGI - HROW
35%
Loosely correlated
+2.48%
AQST - HROW
34%
Loosely correlated
+7.11%
TKNO - HROW
33%
Poorly correlated
+2.83%
AMRX - HROW
32%
Poorly correlated
+0.73%
VTRS - HROW
31%
Poorly correlated
+1.65%
More